Relative contribution of obesity and menopause to the association between serum adiponectin and incident metabolic syndrome

Song Vogue Ahn; Dong Hyuk Jung; Dhananjay Yadav; Jang Young Kim; Sang Baek Koh

doi:10.1097/GME.0000000000000960

Relative contribution of obesity and menopause to the association between serum adiponectin and incident metabolic syndrome

Song Vogue Ahn, Dong Hyuk Jung, Dhananjay Yadav, Jang Young Kim, Sang Baek Koh

Department of Health Convergence

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Objective: Metabolic syndrome is closely linked to obesity. Menopause may play a critical role in understanding the pathophysiology of metabolic syndrome in women. We investigated the relative contribution of obesity and menopause to the association between serum adiponectin levels and the development of metabolic syndrome. Methods: A prospective cohort study was conducted in which a total of 1,219 women without metabolic syndrome were examined at baseline (2005-2008) and followed up (2008-2011). Women were divided according to tertiles of serum adiponectin levels and menopause status, and then stratified into four groups: the nonobese with high adiponectin; the nonobese with low adiponectin; the obese with high adiponectin; and the obese with low adiponectin. Results: During an average 2.5-year follow-up, 44 premenopausal women (9.8%) and 161 postmenopausal women (20.9%) developed metabolic syndrome. The obese group with low serum adiponectin demonstrated an increased risk for developing metabolic syndrome in both premenopausal (odds ratio [OR] 5.92, 95% confidence interval [CI] 2.24-15.66) and postmenopausal women (OR 4.22, 95% CI 2.41-7.36). However, the inverse association between serum adiponectin levels and incidence of metabolic syndrome was observed in premenopausal women with obesity (OR 0.16, 95% CI 0.03-0.81), but not in postmenopausal women with obesity (OR 0.55, 95% CI 0.27-1.14). Conclusions: High serum adiponectin levels showed no inverse association with metabolic syndrome in postmenopausal women with obesity. These findings may suggest a need for closer management of metabolic risk in postmenopausal women.

Original language	English
Pages (from-to)	154-159
Number of pages	6
Journal	Menopause
Volume	25
Issue number	2
DOIs	https://doi.org/10.1097/GME.0000000000000960
State	Published - 1 Feb 2018

Bibliographical note

Funding Information:
Received March 28, 2017; revised and accepted June 28, 2017. From the 1Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea; 2Institute of Genomic Cohort, Yonsei University, Wonju, South Korea; 3Department of Family Medicine, Yonsei University College of Medicine, Yongin, South Korea; 4Department of Medical Biotechnology, Yeungnam University, Gyeong-san, South Korea; and 5Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea. Funding/support: This study was supported in part by a grant from the Korea Centers for Disease Control and Prevention (2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00). Financial disclosure/conflicts of interest: None reported. Address correspondence to: Song Vogue Ahn, MD, PhD, Department of Preventive Medicine, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, Gangwon-do 26426, South Korea. E-mail: dodge@ yonsei.ac.kr

Publisher Copyright:
© 2017 by The North American Menopause Society.

Keywords

Adiponectin
Menopause
Metabolic syndrome
Obesity
Prospective study

Access to Document

10.1097/GME.0000000000000960

Cite this

@article{2f27b066979146d98db98a09b3be80f5,

title = "Relative contribution of obesity and menopause to the association between serum adiponectin and incident metabolic syndrome",

abstract = "Objective: Metabolic syndrome is closely linked to obesity. Menopause may play a critical role in understanding the pathophysiology of metabolic syndrome in women. We investigated the relative contribution of obesity and menopause to the association between serum adiponectin levels and the development of metabolic syndrome. Methods: A prospective cohort study was conducted in which a total of 1,219 women without metabolic syndrome were examined at baseline (2005-2008) and followed up (2008-2011). Women were divided according to tertiles of serum adiponectin levels and menopause status, and then stratified into four groups: the nonobese with high adiponectin; the nonobese with low adiponectin; the obese with high adiponectin; and the obese with low adiponectin. Results: During an average 2.5-year follow-up, 44 premenopausal women (9.8%) and 161 postmenopausal women (20.9%) developed metabolic syndrome. The obese group with low serum adiponectin demonstrated an increased risk for developing metabolic syndrome in both premenopausal (odds ratio [OR] 5.92, 95% confidence interval [CI] 2.24-15.66) and postmenopausal women (OR 4.22, 95% CI 2.41-7.36). However, the inverse association between serum adiponectin levels and incidence of metabolic syndrome was observed in premenopausal women with obesity (OR 0.16, 95% CI 0.03-0.81), but not in postmenopausal women with obesity (OR 0.55, 95% CI 0.27-1.14). Conclusions: High serum adiponectin levels showed no inverse association with metabolic syndrome in postmenopausal women with obesity. These findings may suggest a need for closer management of metabolic risk in postmenopausal women.",

keywords = "Adiponectin, Menopause, Metabolic syndrome, Obesity, Prospective study",

author = "Ahn, {Song Vogue} and Jung, {Dong Hyuk} and Dhananjay Yadav and Kim, {Jang Young} and Koh, {Sang Baek}",

note = "Funding Information: Received March 28, 2017; revised and accepted June 28, 2017. From the 1Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea; 2Institute of Genomic Cohort, Yonsei University, Wonju, South Korea; 3Department of Family Medicine, Yonsei University College of Medicine, Yongin, South Korea; 4Department of Medical Biotechnology, Yeungnam University, Gyeong-san, South Korea; and 5Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea. Funding/support: This study was supported in part by a grant from the Korea Centers for Disease Control and Prevention (2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00). Financial disclosure/conflicts of interest: None reported. Address correspondence to: Song Vogue Ahn, MD, PhD, Department of Preventive Medicine, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, Gangwon-do 26426, South Korea. E-mail: dodge@ yonsei.ac.kr Publisher Copyright: {\textcopyright} 2017 by The North American Menopause Society.",

year = "2018",

month = feb,

day = "1",

doi = "10.1097/GME.0000000000000960",

language = "English",

volume = "25",

pages = "154--159",

journal = "Menopause",

issn = "1072-3714",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "2",

}

TY - JOUR

T1 - Relative contribution of obesity and menopause to the association between serum adiponectin and incident metabolic syndrome

AU - Ahn, Song Vogue

AU - Jung, Dong Hyuk

AU - Yadav, Dhananjay

AU - Kim, Jang Young

AU - Koh, Sang Baek

N1 - Funding Information: Received March 28, 2017; revised and accepted June 28, 2017. From the 1Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea; 2Institute of Genomic Cohort, Yonsei University, Wonju, South Korea; 3Department of Family Medicine, Yonsei University College of Medicine, Yongin, South Korea; 4Department of Medical Biotechnology, Yeungnam University, Gyeong-san, South Korea; and 5Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea. Funding/support: This study was supported in part by a grant from the Korea Centers for Disease Control and Prevention (2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00). Financial disclosure/conflicts of interest: None reported. Address correspondence to: Song Vogue Ahn, MD, PhD, Department of Preventive Medicine, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, Gangwon-do 26426, South Korea. E-mail: dodge@ yonsei.ac.kr Publisher Copyright: © 2017 by The North American Menopause Society.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Objective: Metabolic syndrome is closely linked to obesity. Menopause may play a critical role in understanding the pathophysiology of metabolic syndrome in women. We investigated the relative contribution of obesity and menopause to the association between serum adiponectin levels and the development of metabolic syndrome. Methods: A prospective cohort study was conducted in which a total of 1,219 women without metabolic syndrome were examined at baseline (2005-2008) and followed up (2008-2011). Women were divided according to tertiles of serum adiponectin levels and menopause status, and then stratified into four groups: the nonobese with high adiponectin; the nonobese with low adiponectin; the obese with high adiponectin; and the obese with low adiponectin. Results: During an average 2.5-year follow-up, 44 premenopausal women (9.8%) and 161 postmenopausal women (20.9%) developed metabolic syndrome. The obese group with low serum adiponectin demonstrated an increased risk for developing metabolic syndrome in both premenopausal (odds ratio [OR] 5.92, 95% confidence interval [CI] 2.24-15.66) and postmenopausal women (OR 4.22, 95% CI 2.41-7.36). However, the inverse association between serum adiponectin levels and incidence of metabolic syndrome was observed in premenopausal women with obesity (OR 0.16, 95% CI 0.03-0.81), but not in postmenopausal women with obesity (OR 0.55, 95% CI 0.27-1.14). Conclusions: High serum adiponectin levels showed no inverse association with metabolic syndrome in postmenopausal women with obesity. These findings may suggest a need for closer management of metabolic risk in postmenopausal women.

AB - Objective: Metabolic syndrome is closely linked to obesity. Menopause may play a critical role in understanding the pathophysiology of metabolic syndrome in women. We investigated the relative contribution of obesity and menopause to the association between serum adiponectin levels and the development of metabolic syndrome. Methods: A prospective cohort study was conducted in which a total of 1,219 women without metabolic syndrome were examined at baseline (2005-2008) and followed up (2008-2011). Women were divided according to tertiles of serum adiponectin levels and menopause status, and then stratified into four groups: the nonobese with high adiponectin; the nonobese with low adiponectin; the obese with high adiponectin; and the obese with low adiponectin. Results: During an average 2.5-year follow-up, 44 premenopausal women (9.8%) and 161 postmenopausal women (20.9%) developed metabolic syndrome. The obese group with low serum adiponectin demonstrated an increased risk for developing metabolic syndrome in both premenopausal (odds ratio [OR] 5.92, 95% confidence interval [CI] 2.24-15.66) and postmenopausal women (OR 4.22, 95% CI 2.41-7.36). However, the inverse association between serum adiponectin levels and incidence of metabolic syndrome was observed in premenopausal women with obesity (OR 0.16, 95% CI 0.03-0.81), but not in postmenopausal women with obesity (OR 0.55, 95% CI 0.27-1.14). Conclusions: High serum adiponectin levels showed no inverse association with metabolic syndrome in postmenopausal women with obesity. These findings may suggest a need for closer management of metabolic risk in postmenopausal women.

KW - Adiponectin

KW - Menopause

KW - Metabolic syndrome

KW - Obesity

KW - Prospective study

UR - http://www.scopus.com/inward/record.url?scp=85041560442&partnerID=8YFLogxK

U2 - 10.1097/GME.0000000000000960

DO - 10.1097/GME.0000000000000960

M3 - Article

C2 - 28763403

AN - SCOPUS:85041560442

SN - 1072-3714

VL - 25

SP - 154

EP - 159

JO - Menopause

JF - Menopause

IS - 2

ER -

Relative contribution of obesity and menopause to the association between serum adiponectin and incident metabolic syndrome

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this